Compare Abbott Laboratories (ABT) vs GameStop Corp. (GME) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs GameStop Corp. — how do they compare? Abbott Laboratories trades at $94.9 (market cap $166.94B), while GameStop Corp. trades at $21.74 (market cap $9.96B). The key difference: Abbott Laboratories is far larger — about 16.8× GameStop Corp.'s market cap, and Abbott Laboratories pays a 2.63% dividend while GameStop Corp. pays none. Which is the better fit depends on your goals.
| ABT | GME | |
|---|---|---|
Market Cap | $166.94B | $9.96B |
Sector | Health | Consumer Cyclical |
52-Week High | $136.62 | $27.69 |
52-Week Low | $82.57 | $19.94 |
Enterprise Value | $193.69B | $5.93B |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
GME trades at $22.2, down 2.72% on the day, with a bullish technical signal from moving averages and a neutral stance from oscillators. The company reported a net income margin of 20.45% for 2025, with recent quarterly earnings beating expectations. Key developments include shareholder approval for increased share issuance and CEO Ryan Cohen's focus on a potential eBay acquisition, alongside a withdrawn $35 billion pay package to prioritize the takeover bid.
The outlook is mixed, with strong profitability and bullish technicals offset by a cautious analyst consensus and strategic risks from the eBay pursuit. Investment opportunities lie in continued earnings growth and strategic initiatives, while risks include integration challenges, competitive pressures in physical media, and reliance on CEO-driven strategy.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About GameStop Corp.
Global Market Group Ltd. operates an Internet website that connects Chinese manufacturers with international buyers. The Company's customers can post company profiles and product information in standardized formats; post product listings; and trade leads.
Read more on GME →
